SCHEMBL6749150

SCHEMBL6749150

CN1c2cc(C(=O)O)ccc2Sc2nccnc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.52
MAPT P10636 2/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NOX1 Q9Y5S8 1/20 0.44
HDAC6 Q9UBN7 1/20 0.41
MARK4 Q96L34 2/20 0.39
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
JMJD6 Q6NYC1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6747555 0.80 HDAC6 (0.44) LMNAMAPTHDAC6POLBALDH1A1
SCHEMBL6750180 0.78 HDAC6 (0.43) LMNAMAPTHDAC6POLBMEN1
SCHEMBL9832554 0.73 MAOA (0.55) LMNAMAPTMAPK1TDP1L3MBTL1
SCHEMBL8315505 0.71 HDAC6 (0.45) LMNAMAPTL3MBTL1HDAC6MARK4
SCHEMBL8319484 0.70 HDAC6 (0.42) MAPTL3MBTL1HDAC6POLBICAM1
SCHEMBL8319481 0.70 HDAC6 (0.42) MAPTL3MBTL1HDAC6POLBICAM1
SCHEMBL6747463 0.70 HDAC6 (0.44) LMNAMAPTMAPK1TDP1L3MBTL1
SCHEMBL2636675 0.69 LMNA (1.00) LMNAMAPTMAPK1L3MBTL1POLB
SCHEMBL30270516 0.69 LMNA (1.00) LMNAMAPTMAPK1L3MBTL1POLB
SCHEMBL4908250 0.69 LMNA (0.50) LMNAMAPTMAPK1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092737-A1 Benzopiperidine derivatives EISAI CO., LTD. 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092737-A1 Benzopiperidine derivatives HLA-DRB1, HRH1, HRH2 LMNA 4878/4885MAPT 1257/4885MAPK1 1345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.